Antihypertensive efficacy of once daily MK-521, a new nonsulfhydryl angiotensin-converting enzyme inhibitor
- 1 January 1984
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 53 (1), 116-119
- https://doi.org/10.1016/0002-9149(84)90694-5
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Comparative Antihypertensive Effects of Enalapril Maleate and Hydrochlorothiazide, Alone and in CombinationThe Journal of Clinical Pharmacology, 1983
- Evaluation of the chronotropic property of captopril in hypertensive patientsAmerican Heart Journal, 1982
- Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.British Journal of Clinical Pharmacology, 1982
- Low-Dose CaptoprilArchives of Internal Medicine, 1982
- Captopril: Clinical Pharmacology and Benefit‐to‐Risk Ratio in Hypertension and Congestive Heart FailurePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1982
- ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421".The Lancet, 1981
- Mechanisms by which angiotensin II affects the heart rate of the conscious sheep.Circulation Research, 1980
- Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries.Circulation Research, 1976
- A Radioimmunoassay for Aldosterone in Human Peripheral Plasma Including a Comparison of Alternate TechniquesJournal of Clinical Endocrinology & Metabolism, 1972
- Application of a Radioimmunoassay for Angiotensin I to the Physiologic Measurements of Plasma Renin Activity in Normal Human Subjects1Journal of Clinical Endocrinology & Metabolism, 1969